Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain

Journal of NeuroVirology

Volumn 16, Issue 3, 2010, Pages 230-241

  Lamers, Susanna L ^a   Salemi, Marco ^b   Galligan, Derek C ^c   Morris, Alanna ^c   Gray, Rebecca ^b   Fogel, Gary ^d   Zhao, Li ^e   McGrath, Michael S ^c,f  

^a BIOINFOEXPERTS LLC   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATURAL SELECTION INC   (United States)

^e SHANDONG UNIVERSITY   (China)

^f AIDS and Cancer Specimen Resource   (United States)

Author keywords

Atherosclerosis; CNS infection; Dementia; Genetic analysis; HIV 1 nef; Macrophages; Neuropathology

Indexed keywords

ANTIRETROVIRUS AGENT; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; NEF PROTEIN; VIRUS DNA;

ARTICLE; AUTOPSY; BACTERIAL INFECTION; BRAIN INFECTION; BRAIN TISSUE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; GENE AMPLIFICATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; LYMPHOMATOSIS; MACROPHAGE MIGRATION; MYCOBACTERIUM INTRACELLULARE AVIUM; NEUROPATHOLOGY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AIDS DEMENTIA COMPLEX; AMINO ACID SEQUENCE; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATHEROSCLEROSIS; BAYES THEOREM; BRAIN; CONSENSUS SEQUENCE; DISEASE PROGRESSION; EVOLUTION, MOLECULAR; HIV CORE PROTEIN P24; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; MACROPHAGES; MOLECULAR SEQUENCE DATA; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PHYLOGENY;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MYCOBACTERIUM AVIUM COMPLEX;

EID: 77953208580     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550281003735709     Document Type: Article

References (50)

1. Alexaki A, Liu Y, Wigdahl B(2008). CellularreservoirsofHIV-1 and their role in viral persistence. 1570-162X, Curr HIV Res 6: 388-400.
2. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA (1996). CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955-1958.
3. Cho MW, Lee MK, Carney MC, Berson JF, Doms RW, Martin MA (1998). Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4. 0022-538X 72: 2509-2515.
4. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR (1996). Identification of a major co-receptor for primary isolates of HIV-1. 0028-0836 381: 661-666.
5. Denis M, Ghadirian E (1994). Mycobacterium avium infection in HIV-1-infected subjects increases monokine secretion and is associated with enhanced viral load and diminished immune response to viral antigens. 0009-9104 97: 76-82.
6. Dou H, Kingsley JD, Mosley RL, Gelbard HA, Gendelman HE (2004). Neuroprotective strategies for HIV-1 associated dementia. Neurotox Res 6: 503-521.
7. Fischer-Smith T, Bell C, Croul S, Lewis M, Rappaport J (2008). Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies. 1355-0284 14: 318-326.
8. Fischer-Smith T, Rappaport J (2005). Evolving paradigms in the pathogenesis of HIV-1-associated dementia. Exp Rev Mol Med 7: 1-26.
9. Friis-Moller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, Thiebaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Law MG, Kirk O, Phillips AN, Lundgren JD, Group DCoAEoA-HDDS (2003). Combination antiretroviral therapy and the risk of myocardial infarction. 0028-4793 350: 1993-2003.
10. Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995). Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. 0364-5134 38: 755-762.
11. Gonzalez-Scarano F, Martin-Garcia J (2005). The neuro-pathogenesis of AIDS. 1474-1733 5: 69-81.
12. Gorry PR, Churchill M, Crowe SM, Cunningham AL, Gabuzda D (2005). Pathogenesis of macrophage tropic HIV-1. 1570-162X 3: 53-60.
13. Hammer O, Harper DAT, Ryan PD (2001). PAST: paleon-tological statistics software for education and data analysis. In: Palaeontologia Electronica, 4: art. 4:9pp., http://paleo-electronica.org/2001-1/past/issue1-01.htm
14. HavlirDV,TorrianiFJ, SchrierRD,Huang JY,LedermanMM, Chervenak KA, Boom WH (2001). Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease. 0095-1137 39: 298-303.
15. Holmberg S, Moorman A, Williamson J, Tong T, Ward D, Wood K, Greenberg A, Janssen R (2002). Protease inhibitors and cardiovascular outcomes in patients with HIV-1-1. 0099-5355 360: 1747-1748.
16. Hsue PY, Lo JC, Franklin A, Bolger AF, Martin JN, Deeks SG, Waters DD (2004). Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 109: 1603-1608.
17. Hult B, Chana G, Masliah E, Everall I (2008). Neurobiology of HIV. Int Rev Psychiatry 20: 3-13.
18. Johnson RT, Glass JD, McArthur JC, Chesebro BW (1996). Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome. 0364-5134 39: 392-395.
19. Kramer-Hammerle S, Rothenaigner I, Wolff H, Bell JE, Brack-Werner R (2005). Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. 0168-1702 111: 194-213.
20. Lamers S, Beason S, Dunlap L, Compton R, Salemi M (2004). HIVbase: a PC/Windows-based software offering storage and querying power for locally held HIV-1 genetic, experimental and clinical data. 1367-4803 20: 436-438.
21. Lamers SL, Salemi M, Galligan DC, De Oliveira T, Fogel GB, Granier SC, Zhao L, Brown JN, Morris A, Masliah E, McGrath MS (2009). Extensive HIV-1 intra-host recombination is common in tissues with abnormal histopa-thology. PLoS ONE 4: e5065.
22. Lamers SL, Salemi M, McGrath MS, Fogel GB (2008). Predicting HIV R5, X4 and dual tropic phenotype using evolved neural networks. IEEE/ACM Trans Comput Biol Bioinformatics 5: 291-300.
23. Linton MF, Fazio S (2003). Macrophages, inflammation, and atherosclerosis. 0307-0565 27: S35-S40.
24. MacArthur RD, Lederman MM, Benson CA, Chernoff MC, MacGregor RR, Spritzler J, Mahon LF, Yen-Lieberman B, Purvis S (2000). Effects of Mycobacterium avium complex-infection treatment on cytokine expression in human immunodeficiency virus-infected persons: results of AIDS clinical trials group protocol 853. J Infect Dis 181: 1486-1490.
25. McGrath MS (1997). T-cells and macrophages in HIV disease. Clin Rev Allergy Immunol 14: 359-366.
26. Meng Q, Lima JA, Lai H, Vlahov D, Celentano DD, Strathdee SA, Nelson KE, Wu KC, Chen S, Tong W, Lai S (2002). Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors. Am Heart J 144: 642-648.
27. Milich L, Margolin B, Swanstrom R (1993). V3 loop of the human immunodeficiency virus tye 1 Env protein: interpreting sequence variability. 0022-538X 67: 5623-5634.
28. Monier P, McKown K, Bronze MS (2000). Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus. 1058-4838 31: 1488-1492.
29. Ohagen A, Devitt A, Kunstman K, Gorry P, Rose P, Korber B, Taylor J, Levy R, Murphy R, Wolinsky S, Gabuzda D (2003). Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS. 0022-538X 77: 12336-12345.
30. Palella FJJ, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD (2006). Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 43: 27-34.
31. Ranki A, Nyberg M, Ovod V, Haltia M, Elovaara I, Raininko R, Haapasalo H, Krohn K (1995). Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. 0269-9370 9: 1001-1008.
32. Sacktor N (2002). The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. 1355-0284 8: 115-121.
33. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC, Study MAC (2001a). HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. 0028-3878 56: 257-260.
34. Sacktor N, Tarwater PM, Skolasky RL, McArthur JC, Selnes OA, Becker J, Miller EN, (MACS) MfACS (2001b). CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing. 0028-3878 57: 542-544.
35. Salemi M, Goodenow MM (2008). An exploratory algorithm to identify intra-host recombinant viral sequences. 1055-7903 49: 618-628.
36. Salemi M, Lamers S, Yu S, de Oliveira T, Fitch W, McGrath M (2005). Phylodynamic analysis of human immunodeficiency virus type 1 in distinct brain compartments provides a model for the neuropathogenesis of AIDS. 0022-538X 79: 11343-11352.
37. Stein JH, Klein MA, Bellehumeur JL, McBride PE, Wiebe DA, Otvos JD, Sosman JM (2001). Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation 104: 257-262.
38. Sudano I, Spieker LE, Noll G, Corti R, Weber R, Luscher TF (2006). Cardiovascular disease in HIV infection. Am Heart J 151: 1147-1155.
39. Tamura K, Dudley J, Nei M, Kumar S (2007). MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. 0737-4038 24: 1596-1599.
40. Van Marle G, Power C (2005). Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant? 1355-0284 11: 107-128.
41. Wahl SM, Greenwell-Wild T, Hale-Donze H, Moutsopoulos N, Orenstein JM (2000). Permissive factors for HIV-1 infection of macrophages. 0741-5400 68: 303-310.
42. Wahl SM, Greenwell-Wild T, Peng G, Hale-Donze H, Doherty TM, Mizel D, Orenstein JM (1998). Mycobac-terium avium complex augments macrophage HIV-1 production and increases CCR5 expression. 0027-8424 95: 12574-12579.
43. Wahl SM, Greenwell-Wild T, Peng G, Hale-Donze H, Orenstein JM (1999). Co-infection with opportunistic pathogens promotes human immunodeficiency virus type 1 infection in macrophages. J Infect Dis 179: S457-S460.
44. Wiley CA, Achim CL, Christopherson C, Kidane Y, Kwok S, Masliah E, Mellors J, Radhakrishnan L, Wang G, Soontornniyomkij V (1999). HIV mediates a productive infection of the brain. 0269-9370 13: 2055-2059.
45. Williams K, Corey S, Westmoreland S, Pauley D, Knight H, Debakker C, Alvarez X, Lackner A (2001). Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogen-esis of AIDS. J Exp Med 193: 905-916.
46. Williams KC, Hickey WF (2002). Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. 0147-006X 25: 537-562.
47. Williams R, Dhillon NK, Hegde ST, Yao H, Peng F, Callen S, Chebloune Y, Davis RL, Buch SJ (2009). Proinflam-matory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes. 0894 1491, Glia 57: 734-743.
48. Zarate S, Kosakovsky S, Shapshak P, Frost S (2007). Comparative study of methods for detecting sequence compartmentalization in human immunodeficiency virus type 1. 0022-538X 81: 6643-6651.
49. Zenger E, Abbey NW, Weinstein MD, Kapp L, Reis J, Gofman I, Millward C, Gascon R, Elbaggari A, Herndier BG, McGrath MS (2002). Injection of human primary effusion lymphoma cells or associated macro-phages into severe combined immunodeficient mice causes murine lymphomas. 0008-5472 62: 5536-5542.
50. Zheng J, Thylin MR, Ghorpade A, Xiong H, Persidsky Y, Cotter R, Niemann D, Che M, Zeng YC, Gelbard HA, Shepard RB, Swartz JM, Gendelman HE (1999). Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. 0165-5728 98: 185-200.